Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I-III small cell lung cancerJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-08-0615OAAI
FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I-IIIJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-05-1823OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向